scholarly journals Assessment of Heart Rate Variability derived from Blood Pressure Pulse Recordings in Intensive Care Unit Patients

Author(s):  
Maximiliano Mollura ◽  
Edoardo Maria Polo ◽  
Li-wei Lehman ◽  
Riccardo Barbieri
2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Ann Marie Chiasson ◽  
Ann Linda Baldwin ◽  
Carrol Mclaughlin ◽  
Paula Cook ◽  
Gulshan Sethi

This study was performed to investigate the effect of live, spontaneous harp music on individual patients in an intensive care unit (ICU), either pre- or postoperatively. The purpose was to determine whether this intervention would serve as a relaxation or healing modality, as evidenced by the effect on patient’s pain, heart rate, respiratory rate, blood pressure, oxygen saturation, and heart rate variability. Each consenting patient was randomly assigned to receive either a live 10-minute concert of spontaneous music played by an expert harpist or a 10-minute rest period. Spontaneous harp music significantly decreased patient perception of pain by 27% but did not significantly affect heart rate, respiratory rate, oxygen saturation, blood pressure, or heart rate variability. Trends emerged, although being not statistically significant, that systolic blood pressure increased while heart rate variability decreased. These findings may invoke patient engagement, as opposed to relaxation, as the underlying mechanism of the decrease in the patients’ pain and of the healing benefit that arises from the relationship between healer, healing modality, and patient.


2020 ◽  
Author(s):  
Mohammad Karimi Moridani ◽  
Seyed Kamaledin Setarehdan ◽  
Ali Motie Nasrabadi ◽  
Esmaeil Hajinasrollah

Abstract Background: This article aimed to explore the mortality prediction of cerebrovascular patients in the intensive care unit (ICU) by examining the important signals associated with these patients during different periods of admission in the intensive care unit, which is considered as one of the new topics in the medical field. Several approaches have been proposed for prediction in this area that each of these methods has been able to predict the mortality somewhat, but many of these techniques require the recording of a large amount of data from the patients, where the recording of all data is not possible in most cases; while this article focuses only on the heart rate variability (HRV) and systolic and diastolic blood pressure.Methods: In this paper, using the information obtained from the electrocardiogram (ECG) signal and blood pressure with the help of vital signal processing methods, how to change these signals during the patient's hospitalization will be initially checked. Then, the mortality prediction in patients with cerebral ischemia is evaluated using the features extracted from the return map generated by the signal of heart rate variability and blood pressure. To implement this paper, 80 recorded data from cerebral ischemic patients admitted to the intensive care unit, including ECG signal recording, systolic and diastolic blood pressure, and other physiological parameters are collected. Time of admission and time of death are labeled in all data.Results: The results indicate that the use of the new approach presented in this article can be compared with other methods or leads to better results. The accuracy, specificity, and sensitivity based on the novel features were, respectively, 97.7, 98.9, and 95.4 for cerebral ischemia disease with a prediction horizon of 0.5-1 hours before death.Conclusion: The perspective of the prediction horizons and the patients' length of stay with a new approach was taken into account in this article. The higher the prediction horizon, the nurses or associates of patients have more time to carry out therapeutic measures. To determine the patient's future status and analysis of the ECG signal and blood pressure, at least 7.8 hours of hospitalization is required, which has had a significant reduction compared with other methods.


2020 ◽  
Vol 2020 ◽  
pp. 1-8
Author(s):  
Gilberto Arias-Hernández ◽  
Cruz Vargas-De-León ◽  
Claudia C Calzada-Mendoza ◽  
María Esther Ocharan-Hernández

Background. Postpartum preeclampsia is a serious disease related to high blood pressure that occurs commonly within the first six days after delivery. Objective. To evaluate if diltiazem improves blood pressure parameters in early puerperium patients with severe preeclampsia. Methodology. A randomized, single-blind longitudinal clinical trial of 42 puerperal patients with severe preeclampsia was carried out. Patients were randomized into two groups: the experimental group (n = 21) received diltiazem (60 mg) and the control group (n = 21) received nifedipine (10 mg). Both drugs were orally administered every 8 hours. Systolic, diastolic, and mean blood pressures as well as the heart rate were recorded and analyzed (two-way repeated measures ANOVA) at baseline and after 6, 12, 18, 24, 30, 36, 42, and 48 hours. Primary outcome measures were all the aforementioned blood pressure parameters. Secondary outcome measures included the number of hypertension and hypotension episodes along with the length of stay in the intensive care unit. Results. No statistical differences were found between groups (diltiazem vs. nifedipine) regarding basal blood pressure parameters. Interarm differences in blood pressure (systolic, diastolic, and mean) and heart rate were statistically significant between treatment groups from 6 to 48 hours. Patients in the diltiazem group had lower blood pressure levels than patients in the nifedipine group. Significantly, patients who received diltiazem had fewer hypertension and hypotension episodes and stayed fewer days in the intensive care unit than those treated with nifedipine. Conclusions. Diltiazem controlled arterial hypertension in a more effective and uniform manner in patients under study than nifedipine. Patients treated with diltiazem had fewer collateral effects and spent less time in the hospital. This trial is registered with NCT04222855.


2015 ◽  
Vol 20 (2) ◽  
pp. 112-118 ◽  
Author(s):  
Lauren M. Estkowski ◽  
Jennifer L. Morris ◽  
Elizabeth A. Sinclair

OBJECTIVES: To describe and compare off-label use and cardiovascular (CV) adverse effects of dexmedetomidine in neonates and infants in the pediatric intensive care unit (PICU). METHODS: Patients younger than 12 months with corrected gestational ages of at least 37 weeks who were receiving continuous infusion of dexmedetomidine at a tertiary pediatric referral center between October 2007 and August 2012 were assessed retrospectively. Patients were excluded if dexmedetomidine was used for procedural sedation, postoperative CV surgery, or if postanesthesia infusion weaning orders existed at the time of PICU admission. RESULTS: The median minimum dexmedetomidine dose was similar between infants and neonates at 0.2 mcg/kg/hr (IQR, 0.17–0.3) versus 0.29 mcg/kg/hr (IQR, 0.2–0.31), p = 0.35. The median maximum dose was higher for infants than neonates (0.6 mcg/kg/hr [IQR, 0.4–0.8] vs. 0.4 mcg/kg/hr [IQR, 0.26–0.6], p < 0.01). Additional sedative use was more common in infants than neonates (75/99 [76%] vs. 15/28 [54%], p = 0.02). At least 1 episode of hypotension was noted in 34/127 (27%) patients and was similar between groups. An episode of bradycardia was identified more frequently in infants than neonates (55/99 [56%] vs. 2/28 [7%], p < 0.01). Significant reduction in heart rate and systolic blood pressure was noted when comparing baseline vital signs to lowest heart rate and systolic blood pressure during infusion (p < 0.01). CONCLUSIONS: Dexmedetomidine dose ranges were similar to US Food and Drug Administration–labeled dosages for intensive care unit sedation in adults. More infants than neonates experienced a bradycardia episode, but infants were also more likely to receive higher dosages of dexmedetomidine and additional sedatives.


2018 ◽  
Vol 39 (3) ◽  
pp. 035004 ◽  
Author(s):  
Jooyoung Oh ◽  
Dongrae Cho ◽  
Jaesub Park ◽  
Se Hee Na ◽  
Jongin Kim ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document